Home › Neuroendocrine Tumors › Florida › Miami
Neuroendocrine Tumors clinical trials in Miami, FL
7 studies for Neuroendocrine Tumors are looking for participants at sites in and around Miami (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Carcinoid Syndrome Efficacy Study Featuring an Oral Daily Paltusotine Regimen
RecruitingPhase 3
- University of Miami, Miami
Project: Every Child for Younger Patients With Cancer
RecruitingObservational study
- University of Miami Miller School of Medicine-Sylvester Cancer Center, Miami
- Nicklaus Children's Hospital, Miami
- Miami Cancer Institute, Miami
CapTemY90 for Grade 2/3 NET Liver Metastases
RecruitingPhase 2
- University of Miami Miller School of Medicine-Sylvester Cancer Center, Miami
Targeted Alpha-Particle Therapy for Advanced Somatostatin Receptor Type 2 (SSTR2) Positive Tumors
RecruitingPhase 1/2
- Biogenix Molecular, Miami
SVV-001 With Nivolumab and Ipilimumab in Patients With Poorly Differentiated Neuroendocrine Carcinomas (NEC) or Well-Differentiated High-Grade Neuroendocrine Tumors (NET)
RecruitingPhase 1
- University of Miami, Miami
Study of RYZ101 Compared With SOC in Pts w Inoperable SSTR+ Well-differentiated GEP-NET That Has Progressed Following 177Lu-SSA Therapy
RecruitingPhase 3
- Research Facility, Miami
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RecruitingObservational study
- Massive Bio SYNERGY-AI site, Miami
Neuroendocrine Tumors trials in other cities
- Washington, DC11 studies
- Philadelphia, PA11 studies
- Rochester, MN9 studies
- Houston, TX8 studies
- Salt Lake City, UT8 studies
- Columbus, OH8 studies
- St. Louis, MO8 studies
- Detroit, MI7 studies
- Cedar Rapids, IA7 studies
- Cleveland, OH7 studies
- New York City, NY7 studies
- Lexington, KY7 studies
Other studies in Miami
- Breast Cancer42 studies
- Cancer (all types)36 studies
- Non-Small Cell Lung Cancer31 studies
- Obesity27 studies
- Prostate Cancer27 studies
- Acute Myeloid Leukemia24 studies
- Overweight23 studies
- Ovarian Cancer23 studies
- Metastatic Cancer23 studies
- Ulcerative Colitis22 studies
- Multiple Myeloma21 studies
- Lung Cancer20 studies
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.